Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Gastro-enteropancreatic neuroendocrine tumor × Folfox protocol × Clear all

Sponsor

Conditions

Colorectal Neoplasms 19 Rectal Neoplasms 10 Colonic Neoplasms 6 Pancreatic Neoplasms 4 Stomach Neoplasms 3 Neoplasm Metastasis 3 Adenocarcinoma Of Esophagus 3 Neoplasms 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Pancreatic Adenocarcinoma 1 Ovarian Neoplasms 1 Neuropathy, Painful 1 Neuralgia 1 Neoplasm Recurrence, Local 1 Malignant Solid Tumour 1 Locally Advanced Pancreatic Carcinoma(LAPC) 1 Esophageal Squamous Cell Carcinoma 1 Cold Hypersensitivity 1 Carcinoma, Hepatocellular 1 Carcinoma, Basal Cell 1 Breast Neoplasms 1 Advanced Rectal Cancer 1 Adenocarcinoma of the Lower Rectum 1

Interventions

lutetium Lu 177 dotatate 2 pasireotide 1 folfirinox 1 copper dotatate CU-64 1 arginyllysine 1 Receptor-Like Protein Tyrosine Phosphatases, Class 2 1 Octreotide 1 Nivolumab 1 Lutetium-177 1 Lutetium 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Etoposide 1 Cytokines 1 Cryotherapy 1 Carboplatin 1 Acupuncture Therapy 1 Acupressure 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡